Eloxx Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q2 2011 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Eloxx Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q2 2011 to Q3 2023.
  • Eloxx Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2023 was 3.07M shares, a 96.5% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 3.07M -84M -96.5% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 2.49M -84.6M -97.1% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 2.17M -84.9M -97.5% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 3.07M +892K +41% Dec 31, 2022 10-Q 2023-11-13
Q3 2022 87.1M +552K +0.64% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 87.1M +614K +0.71% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 87.1M +46.6M +115% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 2.18M -38.2M -94.6% Dec 31, 2021 10-K 2023-03-31
Q3 2021 86.5M +46.2M +114% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 86.5M +46.1M +114% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 40.4M +116K +0.29% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 40.4M +164K +0.41% Dec 31, 2020 10-K 2022-03-30
Q3 2020 40.3M +226K +0.56% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 40.3M +284K +0.71% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 40.3M +4.27M +11.8% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 40.2M +4.23M +11.8% Dec 31, 2019 10-K 2021-03-12
Q3 2019 40.1M +4.99M +14.2% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 40M +5.17M +14.8% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 36M +8.52M +31% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 36M +8.42M +30.6% Dec 31, 2018 10-K 2020-03-06
Q3 2018 35.1M -16.3M -31.7% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 34.9M +5.67M +19.4% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 27.5M +607K +2.26% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 27.5M +23.3M +555% Dec 31, 2017 10-K 2019-03-14
Q3 2017 51.4M +30.9M +151% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 29.2M +8.71M +42.5% Jun 30, 2017 10-Q 2017-11-14
Q1 2017 26.9M +6.5M +31.8% Mar 31, 2017 10-Q 2017-05-22
Q4 2016 4.21M -16.2M -79.4% Dec 31, 2016 10-K 2018-03-16
Q3 2016 20.5M +109K +0.53% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 20.5M +1.74M +9.3% Jun 30, 2016 10-K 2017-10-13
Q1 2016 20.4M +6.45M +46.1% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 20.4M +6.55M +47.3% Dec 31, 2015 10-Q 2016-02-16
Q3 2015 20.4M +6.54M +47.2% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 18.8M +4.91M +35.4% Jun 30, 2015 10-K 2016-10-13
Q1 2015 14M +7.08M +103% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 13.9M +8.91M +180% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 13.8M +11.5M +490% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 13.8M +11.6M +509% Jun 30, 2014 10-K 2015-10-09
Q1 2014 6.9M -140M -95.3% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 4.96M -112M -95.8% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 2.35M -114M -98% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 2.27M -91.8M -97.6% Jun 30, 2013 10-K 2014-09-29
Q1 2013 147M +55.1M +60% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 117M +36.1M +44.7% Dec 31, 2012 10-Q 2013-02-14
Q3 2012 117M +37.1M +46.5% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 94.1M +16.3M +21% Jun 30, 2012 10-K 2013-09-11
Q1 2012 91.9M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 80.9M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 79.7M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 77.8M Jun 30, 2011 10-K/A 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.